Medical Devices · Published Aug 2026
Cataract Surgical Devices Market
The global cataract surgical devices market was valued at USD 12,660.0 million in 2025 and is projected to reach USD 21,625.1 million by 2035, expanding at a CAGR of 5.5% over the forecast period. Growth is driven by rising cataract prevalence, technological advancements in surgical devices, and expanding healthcare access in emerging markets. The market remains concentrated among leading medical device manufacturers, with innovation in intraocular lenses and phacoemulsification systems contributing to procedural efficiency and patient outcomes.
Market size
Growth trajectory through 2035
Cataract Surgical Devices Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 Recent developments
- Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals.
-
Development 02 Recent developments
- Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals.
-
Development 03 Recent developments
- Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals.
Emerging opportunities added
- Development of minimally invasive surgical systems Advances in micro-incision technologies and robotic-assisted systems present opportunities to improve procedural efficiency and patient recovery, catering to growing demand for less invasive solutions.
- Growth in premium intraocular lens (IOL) adoption Increasing patient preference for premium IOLs, including multifocal and toric lenses, offers higher-margin opportunities for manufacturers as awareness and affordability improve.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $12.66 Bn
- CAGR
- 5.50%
- Expansion
- 1.7×
Market shape
top segment · 46.7% share
- Leading region
- North America
- Top end-user
- Hospitals
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High cost of advanced devices
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Recent developments: Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals
+2 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 163-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Cataract Surgical Devices Market today ($12.66 Bn base), and how fast will it grow at 5.5% CAGR through 2035?
- Which of Intraocular Lenses (IOLs, Ophthalmic Viscoelastic Devices (OVDs, Phacoemulsification Devices and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Hospital, Ambulatory Surgical Centers (ASCs, Eye Clinics applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Philips Healthcare, Medtronic plc, Abbott Laboratories and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Aging global population) and top restraints (led by High cost of advanced devices), with quantified CAGR impact?
- What regulatory shifts and 3 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Aging global population The rising prevalence of cataracts, closely correlated with age, continues to drive demand for surgical interventions. By 2035, an estimated 2.2 billion people globally will be aged 60 or older, increasing the patient pool for cataract surgeries.
- Technological advancements in devices Innovations such as femtosecond laser-assisted cataract surgery and advanced phacoemulsification systems improve surgical precision, reduce recovery times, and enhance patient outcomes, stimulating adoption.
- Expanding healthcare access in emerging markets Increasing healthcare expenditure and improved access to ophthalmic care in regions such as Asia-Pacific and Latin America are broadening the addressable market for cataract surgical devices.
Restraints
Holding it back
- High cost of advanced devices Premium cataract surgical systems and consumables, such as femtosecond lasers and premium intraocular lenses, pose affordability challenges, particularly in price-sensitive markets.
- Regulatory and reimbursement hurdles Stringent regulatory pathways for device approval and variability in reimbursement policies across countries can delay market entry and limit adoption of innovative technologies.
- Competition from alternative treatments While cataract surgery remains the gold standard, non-surgical interventions and emerging pharmacological therapies for early-stage cataracts may partially offset demand for surgical devices.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging global population | +2.5% | Global | 2025–2035 |
| Technological advancements in devices | +1.5% | Global | 2025–2035 |
| Expanding healthcare access in emerging markets | +1.2% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High cost of advanced devices | −1.0% | Global | 2025–2029 |
| Regulatory and reimbursement hurdles | −0.7% | Global | 2025–2029 |
| Competition from alternative treatments | −0.5% | Global | 2025–2029 |
The cataract surgical devices market is segmented by product type, application, end user, technology, and distribution channel. Product segmentation includes intraocular lenses, surgical devices, and ophthalmic equipment, while applications span hospital settings, ambulatory surgical centers, and eye clinics.
Revenue share by type · 2025 base year
% OF $12.66 BN CATARACT SURGICAL DEVICES MARKET · 3 TYPES COVERED
Each slice = that type's share of the total $12.66 Bn Cataract Surgical Devices Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Intraocular Lenses (IOLs
-
Ophthalmic Viscoelastic Devices (OVDs
-
Phacoemulsification Devices
-
Cataract Surgery Lasers
-
IOL Injectors
By application
-
Hospital
-
Ambulatory Surgical Centers (ASCs
-
Eye Clinics
By end-user industry
-
Hospitals
-
Ambulatory Surgical Centers (ASCs
-
Eye Clinics
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $12.66 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~45.5% in 2025. The region remains a leading market due to high healthcare spending, advanced infrastructure, and strong adoption of premium technologies, with the U.S. contributing the largest share
Per-region detail
-
North America
The region remains a leading market due to high healthcare spending, advanced infrastructure, and strong adoption of premium technologies, with the U.S. contributing the largest share
-
Europe
Growth is driven by an aging population and robust reimbursement frameworks, though market maturity may limit expansion compared to emerging regions
-
Asia-Pacific
Rapid market growth is fueled by increasing cataract prevalence, rising disposable incomes, and expanding healthcare access, particularly in China and India
-
Latin America
Demand is growing as healthcare systems improve, though economic disparities and limited access to advanced devices may constrain market potential
-
Middle East & Africa
The market is developing, with growth opportunities tied to improving healthcare infrastructure and increasing investments in ophthalmic care
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The cataract surgical devices market is moderately concentrated, with leading players focusing on innovation, strategic partnerships, and geographic expansion to maintain market share. Competition is intensifying as new entrants and regional manufacturers target high-growth segments.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Philips Healthcare
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Medtronic plc
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Abbott Laboratories
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Johnson & Johnson MedTech
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Stryker Corporation
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Becton, Dickinson and Company
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Boston Scientific Corporation
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Siemens Healthineers
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA classifies devices by risk (Class I/II/III). 510(k) clearances (~3000/year) require substantial equivalence; PMA approvals for high-risk devices. Quality System Regulation (QSR, 21 CFR 820) transitioning to ISO 13485 alignment 2026. UDI unique device identification mandatory. FDA cybersecurity guidance for connected devices.
-
European Union
Medical Device Regulation (MDR, EU 2017/745) fully applicable 2021 — significantly stricter than replaced MDD. IVDR (in vitro diagnostics) applicable 2022. Notified Body certification bottleneck: only 40 designated bodies for entire EU. Unique Device Identification (UDI) mandatory. EUDAMED database launching in phases.
-
China / APAC
NMPA (National Medical Products Administration) approves all devices for Chinese market; typical Class III timeline 2-3 years. Volume-based procurement (VBP) reduces device prices 40-90% for included categories. Japan's PMDA aligned with FDA on many pathways. India's CDSCO expanded device oversight since 2017.
-
Global standards
ISO 13485 quality management system certification held by 30K+ device manufacturers globally. ISO 14971 risk management mandatory in most jurisdictions. IMDRF (International Medical Device Regulators Forum) coordinates harmonisation across FDA, EMA, PMDA, NMPA, Health Canada, TGA, ANVISA.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,350
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,950
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$6,950
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Cataract Surgical Devices Market in 2025?
The Cataract Surgical Devices Market is estimated at approximately $12.66 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 5.50% CAGR from 2025 to 2035, reaching $21.63 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 45.5% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Intraocular Lenses leads the type segmentation with an estimated 46.7% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Philips Healthcare, Medtronic plc, Abbott Laboratories, Johnson & Johnson MedTech, Stryker Corporation, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Aging global population. The rising prevalence of cataracts, closely correlated with age, continues to drive demand for surgical interventions. By 2035, an estimated 2.2 billion people globally will be aged 60 or older, increasing the patient pool for cataract surgeries.
-
What are the main restraints?
The primary restraint is High cost of advanced devices. Premium cataract surgical systems and consumables, such as femtosecond lasers and premium intraocular lenses, pose affordability challenges, particularly in price-sensitive markets.
-
What are the most recent developments?
Recent notable events include: : Recent developments: Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals; : Recent developments: Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals; : Recent developments: Specific dates and descriptions of recent market developments are currently unavailable, but industry observers anticipate notable progress in device innovation and regulatory approvals. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Cataract Surgical Devices Market is projected to reach $21.63 Bn by 2035, up from $12.66 Bn in 2025 — a 5.50% CAGR equating to roughly 1.7× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.